Each year around 54,000 Australians experience a heart attack. About 60 per cent survive and are recommended to complete cardiac rehabilitation (CR) to reduce the risk of a second heart attack. Cardihab provides convenient CR from wherever you are, using an evidence based, clinically validated smartphone app that shares patient information with a secure clinician web portal. Cardihab has been supported by the ON Accelerate program at CSIRO. http://www.oninnovation.com.au/en/ON-teams/ON-Tribe/Accelerate1/Cardihab
A research team from Australia and the United States, comprised of leading universities, hospitals and industry, will embark on the world's first durable total artificial heart. The group - led by Monash University and BIVACOR, have received $1 million in Australia's Federal Government MRFF funding to develop and commercialise this new device through novel, innovative technology. They aim to take this technology to market within six years, saving lives, creating jobs and establishing Australia as world leaders in medical device development. | https://www.biospectrumasia.com/news/98/18388/australia-us-team-brings-world-first-durable-total-artificial-heart.html
The Microbiome Data Congress 2021 brought together leaders from academia and industry to discuss biostatistical methods and cutting-edge bioinformatic tools for advancing microbiome research. This year's event also featured a session on the 'dark matter' of the gut microbiome and the importance of precise measurements which could lead to diagnostic and therapeutic discovery from the gut. Leading Australian bioinformatician, Dr David Wood of Microba Life Sciences, spoke about the importance of precision microbiome analysis and the potential of the gut microbiome in future diagnostic and therapeutics in clinical practice. | shorturl.at/grCM3
If you could do a saliva test by mail to know if you are at risk of serious illness or death from covid19 based on your genes, what might that mean for vaccination strategies and international border controls?Just such a test has been launched in the US produced by Melbourne company Genetic Technologies Limited.Genomics and AI are part of the technology stack heralding in the era of personalised medicine.The fraught dragnet strategies in public health are set for disruption but privacy issues will need to be overcome.With pinpoint accuracy around risk shouldn't Governments be scrambling?
Lynn Wood
Mel Raassina
Madeline Cunningham
Maria MacNamara
